Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Debt - Additional Information (Detail)

v3.8.0.1
Debt - Additional Information (Detail) - USD ($)
12 Months Ended
Dec. 22, 2016
Dec. 31, 2017
Dec. 31, 2016
Line Of Credit Facility [Line Items]      
Long-term outstanding borrowings   $ 24,516,000 $ 21,799,000
Debt instrument, Weighted average interest rates   5.20%  
Capital Leases [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument, Weighted average interest rates   5.20%  
Term Loan [Member]      
Line Of Credit Facility [Line Items]      
Debt Instrument, maximum borrowing capacity $ 75,000,000    
Line of credit facility incremental borrowing capacity $ 50,000,000    
Current outstanding borrowings   $ 3,700,000  
Long-term outstanding borrowings   66,600,000  
Unamortized transaction costs   $ 884,000  
Interest rate description   (1) the Adjusted LIBOR rate for the relevant interest period, (2) an alternate base rate determined by reference to the greatest of (a) the prime lending rate of Regions, (b) the federal funds rate for the relevant interest period plus 0.5% per annum and (c) the one month LIBOR rate plus 1% per annum, or (3) a combination of (1) and (2). The applicable margin will range from 2.25% to 3.50% for LIBOR loans and 1.25% to 2.50% for base rate loans, in each case based on NeoGenomics Laboratories’ consolidated leverage ratio (as defined in the Credit Agreement). Interest on borrowings under the Revolving Credit Facility is payable on the last day of each month, in the case of each base rate loan, and on the last day of each interest period (but no less frequently than every three months), in the case of Adjusted LIBOR loans. The Company entered into an interest rate swap agreement to hedge against changes in the variable rate of a portion of this debt.  
Debt instrument, maturity date Dec. 21, 2021    
Debt instrument prepayment description   The Credit Agreement requires NeoGenomics Laboratories to mandatorily prepay the Term Loan Facility and amounts borrowed under the Revolving Credit Facility with (i) 100% of net cash proceeds from certain sales and dispositions, subject to certain reinvestment rights, (ii) 100% of net cash proceeds from certain issuances or incurrences of additional debt, (iii) beginning with the fiscal year ending December 31, 2017, 50% of excess cash flow (as defined), subject to a step down to 0% of excess cash flow if NeoGenomics Laboratories’ consolidated leverage ratio is no greater than 2.75:1.0 and (iv) 100% of net cash proceeds from issuances of permitted equity securities by NeoGenomics Laboratories made in order to cure a failure to comply with the financial covenants. NeoGenomics Laboratories is permitted to voluntarily prepay the Term Loan Facility and amounts borrowed under the Revolving Credit Facility at any time without penalty.  
Percentage of net cash proceeds for mandatory prepayment under facility 100.00%    
Percentage of net cash proceeds from issuances or incurrence of additional debt for mandatory prepayment under facility 100.00%    
Leverage ratio used to determine mandatory prepayments under credit facility 275.00%    
Percentage of net cash proceeds from issuances of permitted equity securities to be used for mandatory prepayment under facility 100.00%    
Term Loan [Member] | Leverage Ratio Greater Than Or Equal To 2.75:1.0 [Member]      
Line Of Credit Facility [Line Items]      
Percentage of excess cash flow to be used for mandatory prepayments under facility 50.00%    
Term Loan [Member] | Leverage Ratio Less Than 2.75:1.0 [Member]      
Line Of Credit Facility [Line Items]      
Percentage of excess cash flow to be used for mandatory prepayments under facility 0.00%    
Term Loan [Member] | Federal Funds Rate Plus [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument variable interest rate 0.50%    
Term Loan [Member] | LIBOR Rate Plus [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument variable interest rate 1.00%    
Term Loan [Member] | LIBOR Rate Plus [Member] | Minimum [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument applicable margin 2.25%    
Term Loan [Member] | LIBOR Rate Plus [Member] | Maximum [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument applicable margin 3.50%    
Term Loan [Member] | Base Rate | Minimum [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument applicable margin 1.25%    
Term Loan [Member] | Base Rate | Maximum [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument applicable margin 2.50%    
Auto Loans [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument, Interest rate   0.00%  
Auto Loans [Member] | Minimum [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument, Term   36 months  
Auto Loans [Member] | Maximum [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument, Term   60 months  
Revolving Credit Facility [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument, maturity date Dec. 21, 2021    
Percentage of net cash proceeds for mandatory prepayment under facility 100.00%    
Percentage of net cash proceeds from issuances or incurrence of additional debt for mandatory prepayment under facility 100.00%    
Leverage ratio used to determine mandatory prepayments under credit facility 275.00%    
Percentage of net cash proceeds from issuances of permitted equity securities to be used for mandatory prepayment under facility 100.00%    
Line of credit facility maximum borrowing capacity $ 75,000,000    
Long-term outstanding borrowings   $ 24,500,000  
Unamortized transaction costs   $ 884,000  
Line of credit facility swingline sublimit $ 10,000,000    
Debt instrument description   (1) the Adjusted LIBOR rate for the relevant interest period, (2) an alternate base rate determined by reference to the greatest of (a) the prime lending rate of Regions, (b) the federal funds rate for the relevant interest period plus 0.5% per annum and (c) the one month LIBOR rate plus 1% per annum, or (3) a combination of (1) and (2). The applicable margin will range from 2.25% to 3.50% for Adjusted LIBOR loans and 1.25% to 2.50% for base rate loans, in each case based on NeoGenomics Laboratories’ consolidated leverage ratio.  
Debt instrument prepayment description   The Credit Agreement requires NeoGenomics Laboratories to mandatorily prepay the Term Loan Facility and amounts borrowed under the Revolving Credit Facility with (i) 100% of net cash proceeds from certain sales and dispositions, subject to certain reinvestment rights, (ii) 100% of net cash proceeds from certain issuances or incurrences of additional debt, (iii) beginning with the fiscal year ending December 31, 2017, 50% of excess cash flow (minus certain specified other payments), subject to a step down to 0% of excess cash flow if NeoGenomics Laboratories’ consolidated leverage ratio is no greater than 2.75:1.0 and (iv) 100% of net cash proceeds from issuances of permitted equity securities by NeoGenomics Laboratories made in order to cure a failure to comply with the financial covenants. For the year ended December 31, 2017, no excess cash flow payment was due. NeoGenomics Laboratories is permitted to voluntarily prepay the Term Loan Facility and amounts borrowed under the Revolving Credit Facility at any time without penalty, subject to customary “breakage” costs with respect to prepayments of Adjusted LIBOR rate loans made on a day other than the last day of any applicable interest period.  
Excess cash flow payment due   $ 0  
Revolving Credit Facility [Member] | Leverage Ratio Greater Than Or Equal To 2.75:1.0 [Member]      
Line Of Credit Facility [Line Items]      
Percentage of excess cash flow to be used for mandatory prepayments under facility 50.00%    
Revolving Credit Facility [Member] | Leverage Ratio Less Than 2.75:1.0 [Member]      
Line Of Credit Facility [Line Items]      
Percentage of excess cash flow to be used for mandatory prepayments under facility 0.00%    
Revolving Credit Facility [Member] | Federal Funds Rate Plus [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument variable interest rate 0.50%    
Revolving Credit Facility [Member] | LIBOR Rate Plus [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument variable interest rate 1.00%    
Revolving Credit Facility [Member] | LIBOR Rate Plus [Member] | Minimum [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument variable interest rate 2.25%    
Revolving Credit Facility [Member] | LIBOR Rate Plus [Member] | Maximum [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument variable interest rate 3.50%    
Revolving Credit Facility [Member] | Base Rate | Minimum [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument variable interest rate 1.25%    
Revolving Credit Facility [Member] | Base Rate | Maximum [Member]      
Line Of Credit Facility [Line Items]      
Debt instrument variable interest rate 2.50%